| 11/24/21 |
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
|
| 11/23/21 |
ViewRay Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in connection with Public Offering of Common Stock
|
| 11/19/21 |
ViewRay Announces Closing of Public Offering of Common Stock
|
| 11/16/21 |
ViewRay Announces Pricing of Public Offering of Common Stock
|
| 11/16/21 |
ViewRay Announces Proposed Public Offering of Common Stock
|
| 11/04/21 |
ViewRay Reports Third Quarter 2021 Results
|
| 10/28/21 |
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
|
| 10/25/21 |
Helsinki University Hospital Selects MRIdian® System for Installation at Comprehensive Cancer Center
|
| 10/22/21 |
Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy System
|
| 10/18/21 |
ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on October 28, 2021
|
| 10/14/21 |
ViewRay Announces Conference Call for Third Quarter 2021 Financial Results to be Held After Market on November 4, 2021
|
| 09/29/21 |
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
|
| 09/16/21 |
ViewRay® to Partcipate in the Cantor Global Healthcare Conference
|
| 08/27/21 |
ViewRay® to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
|
| 08/24/21 |
Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience.
|
| 08/17/21 |
UCLA Health Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy
|
| 08/16/21 |
ViewRay Announces Equity Inducement Award under Nasdaq Listing Rule 5635(c)(4)
|
| 08/05/21 |
ViewRay Reports Second Quarter 2021 Results
|
| 07/15/21 |
ViewRay Announces Conference Call for Second Quarter 2021 Financial Results to be Held After Market on August 5, 2021
|
| 07/07/21 |
Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial
|
| 06/24/21 |
GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems
|
| 06/11/21 |
ViewRay Announces Election of Karen N. Prange to its Board of Directors
|
| 05/25/21 |
American Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System
|
| 05/17/21 |
ViewRay® to Present at the Jefferies 2021 Virtual Healthcare Conference
|
| 05/06/21 |
ViewRay Reports First Quarter 2021 Results
|
| 04/19/21 |
ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021
|
| 03/15/21 |
ViewRay Announces Departure of Chief Operating Officer
|
| 03/05/21 |
ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference
|
| 03/04/21 |
ViewRay Reports Fourth Quarter and Full Year 2020 Results
|
| 02/19/21 |
ViewRay Announces Conference Call for Fourth Quarter and Full Year 2020 Financial Results to be Held After Market on March 4, 2021
|
| 02/11/21 |
ViewRay Announces Appointment of Phil Spencer to its Board of Directors
|
| 02/11/21 |
Penn State Health Purchases Second ViewRay MRIdian® Linac
|
| 01/26/21 |
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian® Linac
|
| 01/15/21 |
ViewRay Announces Participation in the B. Riley Oncology Investor Conference
|
| 01/11/21 |
ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference
|
| 01/07/21 |
ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
|
| 01/04/21 |
ViewRay Announces Pricing of Public Offering of Common Stock
|
| 01/04/21 |
ViewRay Announces Proposed Public Offering of Common Stock
|
| 01/04/21 |
ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results
|
